Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
3.138.135.4

Tags: nanocrystals

Peer-reviewed journal (1-4 of 4)

  1. Two-Stage Crystallizer Design for High Loading of Poorly Water-Soluble Pharmaceuticals in Porous Silica Matrices

    09 Jun 2023 | Contributor(s):: Dwyer, L, Kulkarni, SRuelas, L, Myerson, A

    While porous silica supports have been previously studied as carriers for nanocrystalline forms of poorly water-soluble active pharmaceutical ingredients (APIs), increasing the loading of API in these matrices is of great importance if these carriers are to be used in drug formulations. A...

  2. Low Energy Nanoemulsions as Templates for the Formulation of Hydrophobic Drugs

    09 Jun 2023 | Contributor(s):: Badruddoza, AM, Gupta, AMyerson, AS, Trout, BL, Doyle, PS

    Most small molecule active pharmaceutical ingredients (APIs) are hydrophobic which poses formulation challenges due to their poor water solubility. Current approaches are energy intensive and involve presenting the API in a nanoparticle form that is then combined with other additives into a...

  3. Formation of organic molecular nanocrystals under soft confinement

    09 Jun 2023 | Contributor(s):: Yang, XC, Ong, TCMichaelis, VK, Heng, S, Griffin, RG, Myerson, AS

    Methods to produce nano-sized organic molecular crystals in thin films are of great interest in the pharmaceutical industry due to the potential benefit of increased solubility of poorly soluble drugs and the advantages of film-based dosage forms over traditional tablet/capsule-based dosage...

  4. Core-Shell Composite Hydrogels for Controlled Nanocrystal Formation and Release of Hydrophobic Active Pharmaceutical Ingredients

    09 Jun 2023 | Contributor(s):: Badruddoza, AM, Godfrin, PDMyerson, AS, Trout, BL, Doyle, PS

    Although roughly 40% of pharmaceuticals being developed are poorly water soluble, this class of drugs lacks a formulation strategy capable of producing high loads, fast dissolution kinetics, and low energy input. In this work, a novel bottom-up approach is developed for producing and formulating...